Quantum Nano Medicine Research Center

Welcome to Quantum Nano Medicine Research Center

Quantum Nano Medicine Research Center has been approved by Kyoto University as one of its “on-site laboratories” and was opened in October 2019 in the Institute for Integrated Cell-Material Sciences (iCeMS), Institute for Advanced Study. The Center aims to open up a new academic field integrating quantum beams and nanomaterials.

Various types of quantum beams such as X-rays, charged particles, and neutrons, have been generated. Nanomaterials that carry multiple elements that can respond to quantum beams have also been generated. We believe that the integration of these two research areas may lead to medical innovation. The Center also intends to provide a platform for discussion on these points.

Interaction with UCLA

The idea of QNM Center was formulated after the Kyoto University-UCLA symposium, titled "Harnessing physical forces for medical applications - The Convergence of Physics, Nanomaterials, Cell Biology and Cancer Research", held at California NanoSystems Institute (CNSI) of UCLA.

Led by Fuyuhiko Tamanoi, a program-specific professor at iCeMS and professor at UCLA, we plan to hold symposiums and seminar series at both Kyoto University and UCLA to promote academic exchange, exchange of researchers, and student exchange between the two universities.

By interacting with UCLA, we will also function as an exchange hub between Kyoto University and UCLA, contributing to the two universities' research collaboration.

Latest news

Fabruary 14, 2022

New paper is published!!

We have reported that PIP-Based KRAS inhibitor KR12 exhibits excellent tumor accumulation properties. 

Please see details from here.

July 16, 2021

Kyoto University signed a global academic partnership with UCLA. 

Please see details from here. 

July 14, 2021

New paper is published!!

We try to develop a new radiation therapy based on deeper understanding of  the photoelectric effect described by Albert Einstein in 1905.

Please see details from here.